Jäckh R, Rhodes C, Grasso P, Carter J T
Food Chem Toxicol. 1984 Feb;22(2):151-5. doi: 10.1016/0278-6915(84)90096-6.
These studies have provided evidence that DEHP and DEHA do not bind covalently to DNA and do not therefore possess the characteristics of a genotoxic agent (Lutz, 1982). This suggests that the tumours induced in the rodent liver may result from some non-genotoxic mechanism and supports the view that the weakly positive dominant lethal test seen on administration of DEHP by the ip (but not the oral) route (Singh et al. 1974) is unlikely to have resulted from a direct effect on the genome of the sperm cells. Although the mechanism responsible for the induction of tumours by high doses of DEHP in rodents is not clear, it would appear both from these studies and from work on hypolipidaemic agents, that peroxisomal proliferation and the induction of enzymes associated with this organelle are in some way implicated (Cohen & Grasso, 1981). Other studies have shown that changes of this type are produced by doses of hypolipidaemic agents that induce liver cancer in rodents (Cohen & Grasso, 1981) and our investigations have indicated that they were also prominent at dose levels of DEHP similar to those that induced liver cancer in the NCI study (National Toxicology Program, 1982). No cancer induction would be expected to occur in the absence of these changes. In our dose-response study in rats it was shown that at the lowest dose (50 mg/kg body weight/day, approximately equivalent to a dietary level of 1000 ppm) several effects seen with higher doses were not apparent and others differed only slightly from normal control values. This is particularly relevant to assessments of the risk posed by DEHP and DEHA present as contaminants in foods, since human exposure via the food chain has been estimated by Shiota, Chou & Nishimura (1980) as 30 micrograms/kg body weight/day, several orders of magnitude less than the lowest exposure level used in these experiments. In addition, our studies indicate that none of the changes found in the rat were observed in the marmoset, suggesting that rodents and primates differ fundamentally in their hepatic and testicular response to DEHP. Previous studies by other authors (reviewed by Cohen & Grasso, 1981) indicated that morphological changes in the endoplasmic reticulum and the proliferation of peroxisomes are not features of the response of monkeys and man to high doses of hypolipidaemic agents.(ABSTRACT TRUNCATED AT 400 WORDS)
这些研究已提供证据表明,邻苯二甲酸二(2-乙基己基)酯(DEHP)和己二酸二(2-乙基己基)酯(DEHA)不会与DNA发生共价结合,因此不具有基因毒性剂的特征(卢茨,1982年)。这表明在啮齿动物肝脏中诱发的肿瘤可能是由某种非基因毒性机制引起的,并支持这样一种观点,即通过腹腔注射(而非口服)途径给予DEHP时出现的弱阳性显性致死试验(辛格等人,1974年)不太可能是对精子细胞基因组的直接作用所致。尽管高剂量DEHP在啮齿动物中诱发肿瘤的机制尚不清楚,但从这些研究以及关于降血脂剂的研究来看,过氧化物酶体增殖以及与该细胞器相关的酶的诱导在某种程度上似乎与之有关(科恩和格拉索,1981年)。其他研究表明,在啮齿动物中诱发肝癌的降血脂剂剂量会产生这种类型的变化(科恩和格拉索,1981年),而我们的研究表明,在与美国国家癌症研究所(NCI)研究中诱发肝癌的DEHP剂量水平相似的情况下,这些变化也很显著(美国国家毒理学计划,1982年)。在没有这些变化的情况下,预计不会发生癌症诱发。在我们对大鼠的剂量反应研究中发现,在最低剂量(50毫克/千克体重/天,大约相当于饮食水平为1000 ppm)时,高剂量时出现的几种效应并不明显,其他效应与正常对照值相比也仅有轻微差异。这对于评估食品中作为污染物存在的DEHP和DEHA所带来的风险尤为重要,因为据盐田、周和西村(1980年)估计,人类通过食物链的接触量为30微克/千克体重/天,比这些实验中使用的最低接触水平低几个数量级。此外,我们的研究表明,在狨猴中未观察到在大鼠中发现的任何变化,这表明啮齿动物和灵长类动物对DEHP的肝脏和睾丸反应存在根本差异。其他作者先前进行的研究(科恩和格拉索,1981年综述)表明,内质网的形态变化和过氧化物酶体的增殖并非猴子和人类对高剂量降血脂剂反应的特征。(摘要截于400字)